published meta-analysis   sensitivity analysis   studies

corticosteroids in COVID 19 hospitalized - Summary of results

OutcomeTE95% CInkI2ROBPub. bias death D28detailed resultsMetcovid, 2020 0.92 [0.67; 1.28] Tang X, 2020 0.98 [0.93; 1.02] 0.98[0.93; 1.02]Metcovid, 2020, Tang X, 202020%479moderatenot evaluable deathsdetailed resultsCAPE-COVID, 2020 0.45 [0.20; 1.02] Metcovid, 2020 0.92 [0.67; 1.28] Tang X, 2020 0.98 [0.93; 1.02] 0.91[0.73; 1.14]CAPE-COVID, 2020, Metcovid, 2020, Tang X, 2020344%628moderatenot evaluable clinical deteriorationdetailed resultsTang X, 2020 1.00 [0.13; 7.45] 1.00[0.13; 7.45]Tang X, 202010%86NAnot evaluable clinical improvementdetailed resultsTang X, 2020 1.04 [0.67; 1.62] 1.04[0.67; 1.62]Tang X, 202010%86NAnot evaluable clinical improvement (14-day)detailed resultsTang X, 2020 1.33 [0.57; 3.11] 1.33[0.57; 3.11]Tang X, 202010%86NAnot evaluable clinical improvement (time to event analysis only)detailed resultsTang X, 2020 1.04 [0.67; 1.62] 1.04[0.67; 1.62]Tang X, 202010%86NAnot evaluable death or ventilationdetailed resultsCAPE-COVID, 2020 0.71 [0.37; 1.35] 0.71[0.37; 1.35]CAPE-COVID, 202010%149NAnot evaluable hospital dischargedetailed resultsCAPE-COVID, 2020 1.67 [0.87; 3.19] 1.67[0.87; 3.19]CAPE-COVID, 202010%149NAnot evaluable mechanical ventilationdetailed resultsCAPE-COVID, 2020 0.95 [0.44; 2.04] Metcovid, 2020 1.19 [0.56; 2.49] 1.06[0.62; 1.81]CAPE-COVID, 2020, Metcovid, 202020%337moderatenot evaluable viral clearance detailed resultsTang X, 2020 1.78 [1.06; 3.00] 1.78[1.06; 3.00]Tang X, 202010%86NAnot evaluable viral clearance (time to event analysis only)detailed resultsTang X, 2020 1.78 [1.06; 3.00] 1.78[1.06; 3.00]Tang X, 202010%86NAnot evaluable ICU admissiondetailed resultsTang X, 2020 1.00 [0.13; 7.45] 1.00[0.13; 7.45]Tang X, 202010%86NAnot evaluable superinfectiondetailed resultsCAPE-COVID, 2020 0.81 [0.49; 1.34] Metcovid, 2020 0.98 [0.65; 1.47] 0.91[0.66; 1.25]CAPE-COVID, 2020, Metcovid, 202020%542moderatenot evaluable0.55.01.0relative treatment effectwww.metaEvidence.org2024-03-28 19:40 +01:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 95,94,90,91 - treatments: 522,582,666,1149,1150,737,544,733 - roots T: 290